
Peptides
Sous-catégories appartenant à la catégorie "Peptides"
29608 produits trouvés pour "Peptides"
[Tyr34]-Parathyroid Hormone (Bovine, 7-34 amide)
CAS :[Tyr34]-Parathyroid Hormone (Bovine, 7-34 amide) is a product sourced from bovine, is available as a 0.5mg vial and is related to the peptide hormone Parathyroid Hormone (PTH). During abnormal serum calcium levels PTH is secreted from the parathyroid gland, thus regulating calcium and phosphate levels in the body. PTH binds to its PTH receptor which is a G-protein coupled receptor that activated adenylate cyclase or phospholipase C to activate pathways involved in the mediation of bone resorption and bone formation.
Formule :C156H244N48O40S2Degré de pureté :Min. 95%Masse moléculaire :3,496 g/molOrexin-A, Human Antiserum
Orexin-A is a peptide that has been shown to activate orexin receptors, which are ligand-gated ion channels. It is used as a research tool in cell biology and pharmacology. Orexin-A, also known as hypocretin-1, is an endogenous neuropeptide that regulates arousal and wakefulness. The activation of the orexin receptor by Orexin-A leads to the opening of voltage-gated Ca2+ channels, resulting in Ca2+ influx into the cell and increased neurotransmitter release. Orexin-A binds to both orexin receptor subtypes (orexins 1 and 2) with similar affinity but with different binding modes. This antibody can be used for western blotting or immunohistochemistry studies in order to detect the presence of Orexin-A in cells or tissues.Degré de pureté :Min. 95%2'-5' Oligoadenylate Synthetase 1, human, recombinant
The 2'-5' oligoadenylate synthetase 1 (2-5A-1) is a protein that in humans is encoded by the OAS1 gene. This enzyme catalyzes the synthesis of 2'-5' oligoadenylates, which are potent activators of PKC and MAPK. 2-5A-1 has been shown to increase intracellular calcium levels, activate PKC and MAPK, and induce apoptosis in human cells.Degré de pureté :Min. 95%CYP3A4, CYP3A3 MS Calibrator (25nmol)
Cytochrome P450 3A4 is an enzyme that is involved in the metabolism of a wide range of compounds, including drugs and other xenobiotics. CYP3A4 can metabolize a drug from one chemical to another by adding or removing a functional group. CYP3A4 also has monooxygenase activity, meaning it can convert one compound into another using oxygen as a reactant. CYP3A4 is responsible for the metabolism of many drugs and is commonly found in humans, mice, rats, dogs and cattle.
Degré de pureté :Min. 95%Albumin Light Tryptic Peptide Standard (4nmol)
Albumin light tryptic peptide standard for use in protein identification and quantitation studies. Albumin is a globular protein found in plasma and is produced by liver hepatocytes. Serum albumin plays an important role in the regulation of plasma oncotic pressure.Degré de pureté :Min. 95%Anti CCK-8 (Human, Rat) Serum
This is a vivitide catalogue product. Please send your vivitide product enquiry to sales@vivitide.com for an up-to-date price and availability.Degré de pureté :Min. 95%AMP-IBP5, human
CAS :AMP-IBP5, human is a peptide that can be used as a research tool for pharmacological and cell biology studies. It has been shown to inhibit the activity of ion channels, especially those of potassium channels. This peptide also interacts with a number of receptors, including the Ligand-Gated Ion Channel (LGIC), Receptor Tyrosine Kinase (RTK), G Protein-Coupled Receptor (GPCR), and Nuclear Receptor (NR). AMP-IBP5, human is an activator of proteins that are involved in the regulation of cellular signaling pathways. These interactions have been shown to lead to changes in protein expression levels and can be used to study how these proteins interact with each other. AMP-IBP5, human is not active against cells that do not express the receptor or ligand. It has been shown to inhibit the activity of ion channels, especially those of potassium channels. This peptide alsoFormule :C117H188N38O29S2Degré de pureté :Min. 95%Masse moléculaire :2,655.1 g/molAmyloid β-Protein (Human, 1-42) (Scrambled)
Amyloid beta-protein (Aβ) is a peptide that is involved in the pathogenesis of Alzheimer's disease. The protein is a type of amyloid, and it consists of 39-43 amino acid residues. It was originally discovered as a component of the amyloid plaques that are found in the brains of patients with Alzheimer's disease. Aβ is derived from sequential cleavage by enzymes including β-secretase and γ-secretase, which generate a linear peptide composed of residues 1-42. Cleavage by α-secretase prevents production of Aβ. The linear form can be converted to an insoluble form (amyloid fibrils) through sequential exposure to β- or γ- secretases, or to soluble oligomers (Aβ*). These transformations are thought to be involved in the development and progression of Alzheimer's disease. Amyloid beta protein (1-42) has been shown to bind with high affinity toDegré de pureté :Min. 95%Tyrosyl-BNP-32, human
Tyrosyl-BNP-32, human is a peptide that is used as a research tool to study the activation of ion channels and protein interactions. Tyrosyl-BNP-32, human has been shown to be an inhibitor for the receptor for angiotensin II. It also binds to the beta-adrenergic receptor, which is a G protein coupled receptor. Tyrosyl-BNP-32, human is classified as a high purity reagent and has CAS No. 633007-74-2.Formule :C152H253N51O44S4Degré de pureté :Min. 95%Masse moléculaire :3,627.2 g/mol1-Naphthalenylsulfonyl-Ile-Trp-aldehyde
CAS :1-Naphthalenylsulfonyl-Ile-Trp-aldehyde is a recombinant protein that has protease activity. It is a serine protease that cleaves proteins at the amino acid sequence Ser-Xaa-Gly or Ser-Xaa. The recombinant protein has been shown to have proteolytic activity and can be used in assays to measure the amount of β-catenin, collagen, and growth factor in cells. 1-Naphthalenylsulfonyl-Ile-Trp-aldehyde also binds to monoclonal antibodies and can be used as a neutralizing agent for these proteins. This recombinant protein also has been shown to inhibit the growth of lung fibroblasts.Formule :C27H29N3O4SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :491.6 g/molFRETS-25Thr (1 umol) (1umol)
FRETS-25Thr (1 umol) (1umol) is a peptide that was derived from the human erythrocyte membrane protein band 3. It is an activator of ion channels and receptor, and has been shown to inhibit cell proliferation. FRETS-25Thr (1 umol) (1umol) also binds to the C3b component of complement, which is an important part of the immune system.Degré de pureté :Min. 95%Fmoc-N-Amido-dPEG®6-Acid
CAS :Fmoc-N-Amido-dPEG®6-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Fmoc-N-Amido-dPEG®6-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Degré de pureté :Min. 95%Masse moléculaire :575.65 g/molAnti C-Peptide I (Rat) Serum
Anti-C-Peptide I (Rat) Serum is an inhibitor of the C-peptide receptor. It can be used as a research tool to study the activation of the peptide receptor and its interactions with other proteins. Anti-C-Peptide I (Rat) Serum is also an excellent reagent for antibody detection, with high purity and good quality.
Degré de pureté :Min. 95%Tuftsin
CAS :Produit contrôléTuftsin is a cyclic peptide that has been shown to have various biological properties, including anti-inflammatory and immunosuppressive activity. Tuftsin has been shown to inhibit the production of proinflammatory cytokines such as IL-10 by T cells in vitro. Tuftsin also inhibits the activation of toll-like receptors (TLR) and may have a role in inhibiting mycobacterial infection. This drug was found to be well tolerated in humans with congestive heart failure, and is currently being evaluated for its potential use as an adjunct therapy for inflammatory bowel disease. It has also been shown to be effective against opportunistic fungal infections, such as Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus. Tuftsin can be measured using analytical methods such as titration calorimetry or polymerase chain reaction (PCR).Formule :C21H40N8O6•2CH3COOH•4H2ODegré de pureté :Min. 95%Masse moléculaire :692.75 g/molsTfR Heavy Tryptic Peptide Standard (4nmol)
A soluble transferrin receptor (sTfR) heavy tryptic peptide standard for protein identification and quantitation studies. sTfR is a cleaved extracellular segments of the transferrin receptor 1 and it can be used to measure the status of iron in the blood and thus help in studies into anemia, where iron is deficient.Degré de pureté :Min. 95%MAL-dPEG®4-(m-dPEG®12)3
CAS :MAL-dPEG®4-(m-dPEG®12)3 is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. MAL-dPEG®4-(m-dPEG®12)3 is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formule :C84H158N6O40Degré de pureté :Min. 95%Masse moléculaire :1,892.17 g/molRenin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of REN antibody, catalog no. 70R-1584Degré de pureté :Min. 95%SLC7A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC7A1 antibody, catalog no. 70R-6747Degré de pureté :Min. 95%Cytokeratin 19 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KRT19 antibody, catalog no. 70R-3035Degré de pureté :Min. 95%MAT2B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAT2B antibody, catalog no. 70R-3571Degré de pureté :Min. 95%Fibrinogen Alpha Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FGA antibody, catalog no. 70R-5273Degré de pureté :Min. 95%ADAM33 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ADAM33 antibody, catalog no. 70R-5976Degré de pureté :Min. 95%HERC4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HERC4 antibody, catalog no. 70R-2128Degré de pureté :Min. 95%MRPL39 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MRPL39 antibody, catalog no. 70R-2412Degré de pureté :Min. 95%ND5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ND5 antibody, catalog no. 70R-7027Degré de pureté :Min. 95%FEZF1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FEZF1 antibody, catalog no. 70R-8890Degré de pureté :Min. 95%ARL11 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARL11 antibody, catalog no. 70R-3718Degré de pureté :Min. 95%DHX34 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DHX34 antibody, catalog no. 70R-4754Degré de pureté :Min. 95%UBE2C Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBE2C antibody, catalog no. 70R-5585Degré de pureté :Min. 95%ATP1B1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ATP1B1 antibody, catalog no. 70R-6724
Degré de pureté :Min. 95%XYLT2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of XYLT2 antibody, catalog no. 70R-7170
Degré de pureté :Min. 95%DGCR2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DGCR2 antibody, catalog no. 70R-6190Degré de pureté :Min. 95%OXCT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OXCT1 antibody, catalog no. 70R-5323Degré de pureté :Min. 95%UBE4A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBE4A antibody, catalog no. 70R-2780Degré de pureté :Min. 95%CACNB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB1 antibody, catalog no. 70R-5071
Degré de pureté :Min. 95%AADAT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AADAT antibody, catalog no. 70R-1120
Degré de pureté :Min. 95%ALKBH8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ALKBH8 antibody, catalog no. 70R-1459
Degré de pureté :Min. 95%ZNF583 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF583 antibody, catalog no. 70R-8136Degré de pureté :Min. 95%POLB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of POLB antibody, catalog no. 70R-5581Degré de pureté :Min. 95%MGC27016 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MGC27016 antibody, catalog no. 70R-4976Degré de pureté :Min. 95%Tmco3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Tmco3 antibody, catalog no. 70R-8681Degré de pureté :Min. 95%ZNF100 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF100 antibody, catalog no. 70R-8153Degré de pureté :Min. 95%ZNF763 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF763 antibody, catalog no. 20R-1273
Degré de pureté :Min. 95%OSGEP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OSGEP antibody, catalog no. 70R-3839Degré de pureté :Min. 95%HYAL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HYAL1 antibody, catalog no. 70R-9001Degré de pureté :Min. 95%TMEM35 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM35 antibody, catalog no. 70R-7193Degré de pureté :Min. 95%TEX2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TEX2 antibody, catalog no. 70R-6889Degré de pureté :Min. 95%HSPA1L Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HSPA1L antibody, catalog no. 70R-4431Degré de pureté :Min. 95%RHCE Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RHCE antibody, catalog no. 70R-7493Degré de pureté :Min. 95%PPIL2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPIL2 antibody, catalog no. 70R-2300Degré de pureté :Min. 95%PUS10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CCDC139 antibody, catalog no. 70R-3290Degré de pureté :Min. 95%SPDEF Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SPDEF antibody, catalog no. 70R-8298Degré de pureté :Min. 95%SLC35F1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC35F1 antibody, catalog no. 70R-7103Degré de pureté :Min. 95%KEAP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KEAP1 antibody, catalog no. 20R-1096Degré de pureté :Min. 95%IL27 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IL27 antibody, catalog no. 70R-10164Degré de pureté :Min. 95%ST6GALNAC3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ST6GALNAC3 antibody, catalog no. 70R-7175Degré de pureté :Min. 95%CD40 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CD40 antibody, catalog no. 70R-6008Degré de pureté :Min. 95%ATP6V1C1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ATP6V1C1 antibody, catalog no. 70R-2734Degré de pureté :Min. 95%H2AFY Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of H2AFY antibody, catalog no. 70R-2114Degré de pureté :Min. 95%SPR Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SPR antibody, catalog no. 70R-9834Degré de pureté :Min. 95%LARP7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LARP7 antibody, catalog no. 70R-4953Degré de pureté :Min. 95%CACNB4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB4 antibody, catalog no. 70R-5045Degré de pureté :Min. 95%KCNH3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNH3 antibody, catalog no. 70R-5174Degré de pureté :Min. 95%SLC25A21 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25A21 antibody, catalog no. 70R-6493Degré de pureté :Min. 95%GAPDH Blocking Peptide
The GAPDH Blocking Peptide is a powerful tool used in Life Sciences research. It is a ligase that acts as a blocking peptide for glyceraldehyde-3-phosphate dehydrogenase (GAPDH). This peptide specifically inhibits the activity of GAPDH, an essential enzyme involved in glycolysis and other cellular processes. By blocking the function of GAPDH, researchers can study the impact of its inhibition on various cellular pathways and processes. The GAPDH Blocking Peptide is widely used in biochemical and molecular biology studies, providing valuable insights into the role of this enzyme in cellular functions. With its high quality and effectiveness, this peptide is a valuable addition to any research project in the field of Life Sciences.
Degré de pureté :Min. 95%Klotho Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KL antibody, catalog no. 70R-7522Degré de pureté :Min. 95%DISP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DISP1 antibody, catalog no. 70R-6341Degré de pureté :Min. 95%LSS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LSS antibody, catalog no. 70R-2914Degré de pureté :Min. 95%GPD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPD1 antibody, catalog no. 70R-3143Degré de pureté :Min. 95%HHIPL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HHIPL1 antibody, catalog no. 70R-9908Degré de pureté :Min. 95%EIF4E3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EIF4E3 antibody, catalog no. 70R-5011Degré de pureté :Min. 95%Claudin 10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLDN10 antibody, catalog no. 70R-1691Degré de pureté :Min. 95%ADRA1B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ADRA1B antibody, catalog no. 70R-9951Degré de pureté :Min. 95%PHACTR3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PHACTR3 antibody, catalog no. 70R-2298
Degré de pureté :Min. 95%TLK1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TLK1 antibody, catalog no. 70R-5667Degré de pureté :Min. 95%ZFP92 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZFP92 antibody, catalog no. 70R-9045Degré de pureté :Min. 95%GSTA5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GSTA5 antibody, catalog no. 70R-2975
Degré de pureté :Min. 95%C17ORF71 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C17orf71 antibody, catalog no. 70R-4365
Degré de pureté :Min. 95%RLN2
RLN2 is an oncogene that encodes a protein with a sequence of amino acids similar to the anti-cancer drug docetaxel. It is expressed in resistant prostate cancer cells and has been shown to modulate cytogenetics, haematology, and tissue microarrays. The RLN2 gene is also expressed in ligaments and may be associated with chemoresistance.Degré de pureté :Min. 95%CoV-2 S1 (319-529)
COVID-19 is a recombinant protein that was derived from the SARS-CoV. It is an antibody, which binds to the SARS-CoV and prevents it from infecting cells. COVID-19 is a monoclonal antibody that targets the glycoprotein spike of the coronavirus. The 319-529 region of this protein shows high binding affinity for SARS-CoV and SARS-CoV/SARS-CoV-2, which are two types of coronaviruses. This region can be used as a diagnostic marker for these viruses. COVID-19 may also have therapeutic potential as it has shown to neutralize SARS in cell culture and protect mice against lethal challenge with the virus.Degré de pureté :Min. 95%Chlorotrityl Polystyrene Macrobead
Chlorotrityl Polystyrene Macrobeads are anti-cancer agents that can be used for the treatment of a variety of cancers. These macroparticles are composed of a chlorotrityl resin and polystyrene beads. They form a spherical particle with an average diameter of 100 microns, which can be used to encapsulate chemotherapeutic drugs. The chlorotrityl resin is made up of alcohols, amino acids, amines, and cyclic peptides that are soluble in water and have antibacterial and antifungal activities. The macroparticles also contain cyclic molecules with anti-viral activity and anti-cancer properties.Degré de pureté :Min. 95%monoFITC INSL4
MonoFITC INSL4 is a peptide that is used as a research tool. It is an activator of the Insulin-like Growth Factor Receptor 4 (IGF-1R) and can be used to study the protein interactions of the receptor. MonoFITC INSL4 has shown to inhibit the binding of insulin and IGF-1, which are ligands for the receptor. This peptide has also been shown to activate phosphatidylinositol 3-kinase, which is a cellular signalling pathway involved in many cellular processes such as proliferation and apoptosis.
Degré de pureté :Min. 95%Lipoamido-dPEG®8-Acid
CAS :Lipoamido-dPEG®8-Acid is a PEG molecule conjugated with a lipid moiety. Lipoamido-dPEG®8-Acid, conjugated to this lipid constituent, is very important especially in drug delivery and vaccine development as it helps improve the stability and circulation time of lipid nanoparticles (LNPs) and liposomes.
Formule :C41H67F4NO15S2Degré de pureté :Min. 95%Masse moléculaire :954.09 g/molGnGn-bi-Asn-PABA
GnGn-bi-Asn-PABA is a peptide that has been shown to activate the nicotinic acetylcholine receptor. It binds to the ligand binding site of the receptor and mimics the natural neurotransmitter acetylcholine, increasing the probability of neurotransmitter release. GnGn-bi-Asn-PABA has also been shown to inhibit calcium ion channels and ligand gated ion channels, which are proteins that regulate the flow of ions in and out of cells. GnGn-bi-Asn-PABA is a research tool used for studying cell biology and pharmacology.Formule :C63H103N9O37Degré de pureté :Min. 95%Masse moléculaire :1,578.5 g/molDOTA-tris(Acid)-Amido-dPEG®24-TFP Ester
DOTA-tris(Acid)-Amido-dPEG®24-TFP Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. DOTA-tris(Acid)-Amido-dPEG®24-TFP Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Degré de pureté :Min. 95%Masse moléculaire :1,908.86 g/molAc-Gly-Lys-OMe • AcOH [AGLME]
CAS :Ac-Gly-Lys-OMe • AcOH is a synthetic substrate that is used in enzymatic reactions. This product is a peptide that contains an amide bond and a disulfide bond. It has been shown to be inactive when exposed to human serum for up to 30 minutes. Ac-Gly-Lys-OMe • AcOH has been shown to have inhibitory effects on the activity of monoclonal antibodies as well as dodecyl, which belongs to the group of lipids found in blood plasma. The rate of this reaction increases with increasing temperature and pH, but decreases with increasing concentrations of AGLME or dodecanol.Formule :C11H21N3O4•CH3COOHDegré de pureté :Min. 95%Masse moléculaire :319.35 g/molMAL-dPEG®8-t-Boc-Hydrazide
CAS :MAL-dPEG®8-t-Boc-Hydrazide is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. MAL-dPEG®8-t-Boc-Hydrazide is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formule :C31H54N4O14Degré de pureté :Min. 95%Masse moléculaire :706.78 g/molPhth-dPEG®4-Tris(-TFP Ester)3
Phth-dPEG®4-Tris(-TFP Ester)3 is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Phth-dPEG®4-Tris(-TFP Ester)3 is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formule :C50H46F12N2O16Degré de pureté :Min. 95%Masse moléculaire :1,158.88 g/molBiotin-dPEG®3-TFPA
CAS :Biotin-dPEG®3-TFPA is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Biotin-dPEG®3-TFPA is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formule :C27H37F4N7O6SDegré de pureté :Min. 95%Masse moléculaire :663.69 g/molH2N-PEG-O-C3H6-COOH hydrochloride
H2N-PEG-O-C3H6-COOH hydrochloride is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. H2N-PEG-O-C3H6-COOH hydrochloride is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Degré de pureté :Min. 95%Methoxytrityl-S-dPEG®4-Acid
CAS :Methoxytrityl-S-dPEG®4-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Methoxytrityl-S-dPEG®4-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.
Formule :C51H103NO26Degré de pureté :Min. 95%Masse moléculaire :1,146.35 g/molHydroxy-dPEG®8-t-Butyl Ester
CAS :Hydroxy-dPEG®8-t-Butyl Ester is a PEG polymer categorised as monofunctional (OH-PEG-X). Used as a linker, hydroxy-dPEG®8-t-Butyl Ester is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.
Degré de pureté :Min. 95%Masse moléculaire :498.6 g/molHGF Human CHO
HGF is a cytokine that is thought to play an important role in the development of cancer. HGF stimulates the proliferation, differentiation, and survival of cells and acts as a chemoattractant for cells. It is also known to inhibit apoptosis and promote angiogenesis. HGF has been found in many human tissues, including liver, lung, kidney, heart, muscle, pancreas and brain. HGF is a member of the platelet-derived growth factor family and can be used as a marker for certain types of cancer.Degré de pureté :Min. 95%Anti GIP (Rat) Serum
Anti-GIP (Rat) Serum is a recombinant, affinity-purified antibody that recognizes the peptide sequence of rat GIP. Anti-GIP (Rat) Serum is an important research tool used in the study of protein interactions, activation, ligand binding, and receptor activation. It can also be used to inhibit GIP activity by blocking the binding site on the receptor. Anti-GIP (Rat) Serum is available in high purity and at competitive pricing.Degré de pureté :Min. 95%Matrix Metalloproteinase-13, human, recombinant
Matrix Metalloproteinase-13 is a metalloproteinase with a broad substrate specificity. It is used as a prognostic factor for cancer patients, and is also used to diagnose and monitor inflammatory bowel disease. In addition, it has been shown to have chemiluminescence activity in the presence of hydrogen peroxide. The MMP-13 protein can be detected using Western blotting with monoclonal antibodies against the human MMP-13 protein. This recombinant human Matrix Metalloproteinase-13 (rMMP-13) can be used as an antigen for immunoassays such as ELISA and RIA.Degré de pureté :Min. 95%Leptin (Rat)-ELISA Kit (1ea)
Leptin ELISA Kit is a sandwich ELISA for the quantitative measurement of mouse leptin in rat serum. Leptin is a 16-kDa peptide hormone that regulates energy balance and body weight. It is produced by adipose tissue, and circulates in the blood as a protein complex with high-density lipoprotein (HDL). The assay employs monoclonal antibodies (MAbs) to measure mouse leptin in rat serum. The Mabs are specific for the mouse leptin sequence, which allows them to selectively bind to the mouse leptin in rat serum. Quantitative measurements of mouse leptin can be made using standard colorimetric procedures.Degré de pureté :Min. 95%Anti CGRP (Rat) Serum
Anti CGRP (Rat) Serum is a research tool used to study the function of calcitonin gene-related peptide (CGRP) in cell biology. It is an antibody that binds to the CGRP receptor and blocks the activation of ion channels, which are important for pain perception. This serum can be used as a blocking agent in experiments to study the effects of CGRP on cells.Degré de pureté :Min. 95%DOTA-tris(Acid)-Amido-dPEG®11-Bromoacetamide
DOTA-tris(Acid)-Amido-dPEG®11-Bromoacetamide is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. DOTA-tris(Acid)-Amido-dPEG®11-Bromoacetamide is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Degré de pureté :Min. 95%Masse moléculaire :1,280.06 g/molATIII Light Tryptic Peptide Standard (4nmol)
Antithrombin III light tryptic peptide standard for protein identification and quantitation studies. Antithrombin III is a glycoprotein found in blood plasma and is involved in the regulation of the coagulation process.Degré de pureté :Min. 95%Anti Urocortin (3-40) Serum
Anti Urocortin (3-40) Serum is a peptide that can be used as a research tool to activate ion channels and ligand receptors. This product is a high purity, lyophilized serum that can be reconstituted with water. Anti Urocortin (3-40) Serum has been shown to inhibit protein interactions in the cell biology and pharmacology fields. The CAS number for this product is 103425-75-4.Degré de pureté :Min. 95%
